<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Poor prognosis &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/poor-prognosis/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 14:11:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Poor prognosis &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Complex KIT-Negative AML Subgroup Shows Poor Prognosis</title>
		<link>https://bioengineer.org/complex-kit-negative-aml-subgroup-shows-poor-prognosis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 14:10:40 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Acute myeloid leukemia prognosis]]></category>
		<category><![CDATA[AML genetic subgroups]]></category>
		<category><![CDATA[CBF-negative leukemia]]></category>
		<category><![CDATA[İşte içerikle en uyumlu 5 etiket: **KIT mutant/CBF-negative AML]]></category>
		<category><![CDATA[Makalenin içeriğine ve anahtar vurgularına göre en uygun 5 etiket: **KIT mutant AML]]></category>
		<category><![CDATA[Personalized medicine in AML** **Açıklama:** 1. **KIT mutant AML:** Makalenin temel odağı KIT gen mutasyonu olan AML hastaları. 2. **CBF-negative leukemia:** KIT mutasyon]]></category>
		<category><![CDATA[Poor prognosis]]></category>
		<category><![CDATA[Targeted therapy** * **KIT mutant/CBF-negative AML:** Doğrudan makalenin incelediği spesifik alt grubu tanımlar. * **Poor prognosis:** Makalenin ana bulgusunu vurgular (bu alt grubun kötü se]]></category>
		<guid isPermaLink="false">https://bioengineer.org/complex-kit-negative-aml-subgroup-shows-poor-prognosis/</guid>

					<description><![CDATA[Recent advancements in the understanding of acute myeloid leukemia (AML) have shed light on the complexities associated with the disease, particularly regarding certain subgroups characterized by specific genetic mutations and markers. A groundbreaking study conducted by Jiang et al. (2026) delves into the prognosis of subtypes of AML, specifically those with mutations in the KIT [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318953</post-id>	</item>
	</channel>
</rss>
